Cervical Cancer Vaccine India
- All
- News
- Videos
-
Can HPV Vaccine Help Prevent Cervical Cancer In Women?
HPV Vaccine For Women: The HPV vaccine is a critical preventive measure, significantly reducing the risk of cervical cancer. Women are advised to get the HPV vaccine starting at the age of 11 or 12, though it can be given as early as age 9 and up to age 26 for those who missed earlier vaccination.
-
Serum Institute Boosts Supply Of Cervical Cancer Shots Ahead Of Mass Drive
Serum Institute of India aims to significantly boost supply of its human papillomavirus (HPV) vaccine as it gears up to provide its shots to the government at cheaper rates for an immunisation campaign this year against the cancer-causing virus.
-
Why Cervical Cancer Is Dangerous? Experts Explain
As Cervical cancer is the second-leading cause of deaths among women in India is exploring options to cap prices so that the vaccines to treat cervical cancer become more affordable, official sources have said.
-
Over 3.4 Lakh Cervical Cancer Cases In India In 2023: Parliament Informed
According to the Indian Council of Medical Research's National Cancer Registry Programme (ICMR-NCRP), the estimated number of cervical cancer cases in the country in 2023 was more than 3.4 lakh, the government informed Parliament.
-
"Not True": Centre On Launch Of Cervical Cancer Vaccination Campaign Later This Year
The Centre on Saturday said it is yet to take a decision on the roll-out of human papillomavirus (HPV) vaccination against cervical cancer in the country.
-
Made In India HPV Vaccine May Be Considered For Immunisation: Centre
The indigenously developed quadrivalent HPV vaccine may be considered for introduction in the Universal Immunisation programme (UIP) as a two-dose regimen for adolescent girls aged 9-14 years, Rajya Sabha was informed today.
-
Serum Institute's Cervical Cancer Vaccine To Hit Market This Month: Report
The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per vial of two doses, official sources said on Thursday.
-
Production Of Cervical Cancer Vaccine To Increase In 2024: Adar Poonawalla
A day after the first indigenously developed Human Papillomavirus vaccine against cervical cancer was launched, Serum Institute of India CEO Adar Poonawalla on Wednesday said the vaccine will be available in small quantity this year.
-
Vaccine Against Cervical Cancer To Be In Immunisation Programme By Mid-2023
India would be in a position to roll out the indigenously developed Human Papillomavirus Vaccine (HPV) against cervical cancer for girls in the age group of 9-14 under the National Immunisation Programme by mid-2023, NTAGI chairperson Dr NK Arora sai
-
Cervical Cancer Vaccine Could Be Developed In India by April-May 2023: Medical Panel Chief
The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by April at the one-tenth of the cost of internationally branded vaccines in the country.
-
Cervical Cancer Vaccine To Be Launched In India Next Year: Adar Poonawalla
Serum Institute of India (SII) had to defer HPV vaccine production by two years due to the focus on Covid, and will start supplying small quantities of the dose to the Indian government in early 2023, a top official has said.
-
Cancer: As Vaccine Against Cervical Cancer Launches In India, Here Are 4 Other Cancers To Beware Of Besides Cervical Cancer
Cancer: In this article, we discuss various other cancers that are extremely common.
-
Cervical Cancer: Here Are 7 Facts About Cervical Cancer Every Women Should Know
Cervical Cancer: In this article, we list some of the most common facts about cervical cancer that every woman should be aware of.
-
Cervical Cancer: As The Vaccine Launches Against CC, Let's Understand The Causes And Risks
Cervical Cancer Vaccine: Here is everything you need to know about Cervical Cancer and its risk and causes.
-
Cervical Cancer: Here's What We Know About The Availability, Price, Etc.
ANI: India's first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine will be available at an affordable price.
-
Can HPV Vaccine Help Prevent Cervical Cancer In Women?
HPV Vaccine For Women: The HPV vaccine is a critical preventive measure, significantly reducing the risk of cervical cancer. Women are advised to get the HPV vaccine starting at the age of 11 or 12, though it can be given as early as age 9 and up to age 26 for those who missed earlier vaccination.
-
Serum Institute Boosts Supply Of Cervical Cancer Shots Ahead Of Mass Drive
Serum Institute of India aims to significantly boost supply of its human papillomavirus (HPV) vaccine as it gears up to provide its shots to the government at cheaper rates for an immunisation campaign this year against the cancer-causing virus.
-
Why Cervical Cancer Is Dangerous? Experts Explain
As Cervical cancer is the second-leading cause of deaths among women in India is exploring options to cap prices so that the vaccines to treat cervical cancer become more affordable, official sources have said.
-
Over 3.4 Lakh Cervical Cancer Cases In India In 2023: Parliament Informed
According to the Indian Council of Medical Research's National Cancer Registry Programme (ICMR-NCRP), the estimated number of cervical cancer cases in the country in 2023 was more than 3.4 lakh, the government informed Parliament.
-
"Not True": Centre On Launch Of Cervical Cancer Vaccination Campaign Later This Year
The Centre on Saturday said it is yet to take a decision on the roll-out of human papillomavirus (HPV) vaccination against cervical cancer in the country.
-
Made In India HPV Vaccine May Be Considered For Immunisation: Centre
The indigenously developed quadrivalent HPV vaccine may be considered for introduction in the Universal Immunisation programme (UIP) as a two-dose regimen for adolescent girls aged 9-14 years, Rajya Sabha was informed today.
-
Serum Institute's Cervical Cancer Vaccine To Hit Market This Month: Report
The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, will be available in the market this month at an MRP of Rs 2,000 per vial of two doses, official sources said on Thursday.
-
Production Of Cervical Cancer Vaccine To Increase In 2024: Adar Poonawalla
A day after the first indigenously developed Human Papillomavirus vaccine against cervical cancer was launched, Serum Institute of India CEO Adar Poonawalla on Wednesday said the vaccine will be available in small quantity this year.
-
Vaccine Against Cervical Cancer To Be In Immunisation Programme By Mid-2023
India would be in a position to roll out the indigenously developed Human Papillomavirus Vaccine (HPV) against cervical cancer for girls in the age group of 9-14 under the National Immunisation Programme by mid-2023, NTAGI chairperson Dr NK Arora sai
-
Cervical Cancer Vaccine Could Be Developed In India by April-May 2023: Medical Panel Chief
The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by April at the one-tenth of the cost of internationally branded vaccines in the country.
-
Cervical Cancer Vaccine To Be Launched In India Next Year: Adar Poonawalla
Serum Institute of India (SII) had to defer HPV vaccine production by two years due to the focus on Covid, and will start supplying small quantities of the dose to the Indian government in early 2023, a top official has said.
-
Cancer: As Vaccine Against Cervical Cancer Launches In India, Here Are 4 Other Cancers To Beware Of Besides Cervical Cancer
Cancer: In this article, we discuss various other cancers that are extremely common.
-
Cervical Cancer: Here Are 7 Facts About Cervical Cancer Every Women Should Know
Cervical Cancer: In this article, we list some of the most common facts about cervical cancer that every woman should be aware of.
-
Cervical Cancer: As The Vaccine Launches Against CC, Let's Understand The Causes And Risks
Cervical Cancer Vaccine: Here is everything you need to know about Cervical Cancer and its risk and causes.
-
Cervical Cancer: Here's What We Know About The Availability, Price, Etc.
ANI: India's first indigenously developed quadrivalent Human Papilloma Virus (qHPV) vaccine will be available at an affordable price.
